Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: Properties of the NS5A-associated kinase

Journal of Virology

Volumn 71, Issue 10, 1997, Pages 7187-7197

  Reed, Karen E ^a   Xu, Jian ^a   Rice, Charles M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL STRAIN BHK; CELL STRAIN COS1; CONTROLLED STUDY; HELA CELL; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; VIRUS CELL INTERACTION;

EID: 0030828466     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.10.7187-7197.1997     Document Type: Article

References (51)

1. Abraham, R. T., M. Acquarone, A. Andersen, A. Asensi, R. Bellé, F. Berger, C. Bergounioux, G. Brunn, C. Buquet-Fagot, D. Fagot, N. Glab, H. Goudeau, M. Goudeau, P. Guerrier, P. Houghton, H. Hendriks, B. Kloareg, M. Lippai, D. Marie, B. Maro, L. Meijer, J. Mester, O. Mulner-Lorillon, S. A. Poulet, E. Schierenberg, B. Schutte, D. Vaulot, and M. H. Verlhac. 1995. Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases. Biol. Cell 83:105-120.
2. Agapov, E. V., and C. M. Rice. Unpublished data.
3. Agostinis, P., A. Vandenbogaerde, A. Donella-Deana, L. A. Pinna, K.-T. Lee, J. Goris, W. Merlevede, J. R. Vandenheede, and P. De Witte. 1995. Photosensitized inhibition of growth factor-regulated protein kinases by hypericin. Biochem. Pharmacol. 49:1615-1622.
4. Alberts, B., D. Bray, J. Lewis, M. Raff, K. Roberts, and J. D. Watson. 1994. Molecular biology of the cell. Garland Publishing, Inc., New York, N.Y.
5. Alter, M. J. 1995. Epidemiology of hepatitis C in the West. Semin. Liver Dis. 15:5-14
6. Asabe, S.-I., Y. Tanji, S. Satoh, T. Kaneko, K. Kimura, and K. Shimotohno. 1997. The N-terminal region of hepatitis C virus-encoded NS5A is important for NS4A-dependent phosphorylation. J. Virol. 71:790-796.
7. Barik, S., and A. K. Banerjee. 1992. Phosphorylation by cellular casein kinase II is essential for transcriptional activity of vesicular stomatitis virus phosphoprotein P. Proc. Natl. Acad. Sci. USA 89:6570-6574.
8. Barik, S., and A. K. Banerjee. 1992. Sequential phosphorylation of the phosphoprotein of vesicular stomatitis virus by cellular and viral protein kinases is essential for transcription activation. J. Virol. 66:1109-1118.
9. Byrappa, S., Y.-B. Pan, and K. C. Gupta. 1996. Sendai Virus P protein is constitutively phosphorylated at Serine249: high phosphorylation potential of the P protein. Virology 216:228-234.
10. Chijiwa, T., A. Mishima, M. Hagiwara, M. Sano, K. Hayashi, T. Inoue, K. Naito, T. Toshioka, and H. Hidaka. 1990. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265:5267-5272.
11. Das, T., A. Schuster, S. Schneider-Schaulies, and A. K. Banerjee. 1995. Involvement of cellular casein kinase II in the phosphorylation of measles virus P protein: identification of phosphorylation sites. Virology 211:218-226.
12. De, B. P., S. Gupta, S. Gupta, and A. K. Banerjee. 1995. Cellular protein kinase C isoform ζ regulates human parainfluenza virus type 3 replication. Proc. Natl. Acad. Sci. USA 92:5204-5208.
13. Enomoto, N., I. Sakuma, Y. Asahina, M. Kurosaki, T. Murakami, C. Yamamoto, N. Izumi, F. Marumo, and C. Sato. 1995. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. J. Clin. Invest. 96:224-230.
14. Enomoto, N., I. Sakuma, Y. Asahina, M. Kurosaki, T. Murakami, C. Yamamoto, Y. Ogura, N. Izumi, F. Marumo, and C. Sato. 1996. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N. Engl. J. Med. 334:77-81.
15. Fuerst, T. R., E. G. Niles, F. W. Studier, and B. Moss. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8126.
16. Gale, M. J., Jr., M. J. Korth, N. M. Tang, S.-L. Tan, D. A. Hopkins, T. E. Dever, S. J. Polyak, D. R. Gretch, and M. G. Katze. 1997. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230:217-227.
17. Grakoui, A., C. Wychowkski, C. Lin, S. M. Feinstone, and C. M. Rice. 1993. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67:1385-1395.
18. Hardie, G., and S. Hanks (ed.). 1995. The protein kinase facts book: proteinserine kinases. Academic Press, Inc., San Diego, Calif.
19. Heilmeyer, L. M. G., Jr. 1991. Molecular basis of signal integration in phosphorylase kinase. Biochim. Biophys. Acta 1094:168-174.
20. Hijikata, M., H. Mizushima, Y. Tanji, Y. Komoda, Y. Hirowatari, T. Akagi, N. Kato, K. Kimura, and K. Shimotohno. 1993. Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc. Natl. Acad. Sci. USA 90:10773-10777.
21. Ide, Y., L. Zhang, M. Chen, G. Inchauspe, C. Bahl, Y. Sasaguri, and R. Padmanabhan. 1996. Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A. Gene 182:203-211.
22. Inagaki, M., S. Kawamoto, H. Itoh, M. Saitoh, M. Hagiwara, J. Takahashi, and H. Hidaka. 1986. Napthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors. Mol. Pharmacol. 29:577-581.
23. Kaelin, W. G., Jr., D. C. Pallas, J. A. DeCaprio, F. J. Kaye, and D. M. Livingston. 1991. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell 64:521-532.
24. Kaneko, T., Y. Tanji, S. Satoh, M. Hijikata, S. Asabe, K. Kimura, and K. Shimotohno. 1994. Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. Biochem. Biophys. Res. Commun. 205:320-326.
25. Kapoor, M., L. Zhang, M. Ramachandra, J. Kusukawa, K. E. Ebner, and R. Padmanabhan. 1995. Association between NS3 and NS5 proteins of dengue virus type 2 in the putative RNA replicase is linked to differential phosphorylation of NS5. J. Biol. Chem. 270:19100-19106.
26. Kolykhalov, A. A., and C. M. Rice. Unpublished data.
27. Kolykhalov, A. A., E. V. Agapov, K. J. Blight, K. Mihalik, S. M. Feinstone, and C. M. Rice. 1997. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 277:570-574.
28. LaStarza, M. W., A. Grakoui, and C. M. Rice. 1994. Deletion and duplication mutations in the C-terminal nonconserved region of Sindbis virus: effects on phosphorylation and on virus replication in vertebrate and invertebrate cells. Virology 202:224-232.
29. Lemm, J. A., and C. M. Rice. 1993. Assembly of functional Sindbis virus RNA replication complexes: requirement for coexpression of P123 and P34. J. Virol. 67:1905-1915.
30. Li, G., M. W. LaStarza, W. R. Hardy, J. H. Strauss, and C. M. Rice. 1990. Phosphorylation of Sindbis virus nsP3 in vivo and in vitro. Virology 179:416-427.
31. Lin, C., B. Prágai, A. Grakoui, J. Xu, and C. M. Rice. 1994. The hepatitis C virus NS3 serine proteinase: trans processing requirements and cleavage kinetics. J. Virol. 68:8147-8157.
32. Lin, C., and C. M. Rice. Unpublished data.
33. Manabe, S., I. Fuke, O. Tanishita, C. Kaji, Y. Gomi, S. Yoshida, C. Mori, A. Takamizawa, I. Yoshida, and H. Okayama. 1994. Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3. Virology 198:636-644.
34. Mansell, C. J., and S. A. Locarnini. 1995. Epidemiology of hepatitis C in the East. Semin. Liver Dis. 15:15-32.
35. 237 as the site of phosphorylation by cellular casein kinase II. Virology 205:93-103.
36. Mazumder, B., and S. Barik. 1994. Requirement of casein kinase II-mediated phosphorylation for the transcriptional activity of human respiratory syncytial viral phosphoprotein P: transdominant negative phenotype of phosphorylation-defective P mutants. Virology 205:104-111.
37. Moss, B., O. Elroy-Stein, T. Mizukami, W. A. Alexander, and T. R. Fuerst. 1990. New mammalian expression vectors. Nature (London) 348:91-92.
38. Nakabayashi, H., K. Taketa, K. Miyano, T. Yamane, and J. Sato. 1982. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res. 42:3858-3863.
39. Okamoto, H., S. Okada, Y. Sugiyama, K. Kurai, H. Iizuka, A. Machida, Y. Miyakawa, and M. Mayumi. 1991. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. J. Gen. Virol. 72: 2697-2704.
40. Omura, S., Y. Sasaki, Y. Iwai, and H. Takeshima. 1995. Staurosporine, a potentially important gift from a microorganism. J. Antibiot. 48:535-548.
41. Reed, K. E., and C. M. Rice. Molecular characterization of hepatitis C virus. In H. W. Reesink (ed.), Hepatitis C virus, in press. Karger, Basel, Switzerland.
42. Rice, C. M. 1996. Flaviviridae: the viruses and their replication, p. 931-960. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology. Lippincott-Raven Publishers, Philadelphia, Pa.
43. Sharara, A. I., C. M. Hunt, and J. D. Hamilton. 1996. Hepatitis C. Ann. Intern. Med. 125:658-668.
44. Tanji, Y., T. Kaneko, S. Satoh, and K. Shimotohno. 1995. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J. Virol. 69:3980-3986.
45. Toullec, D., P. Pianetti, H. Coste, P. Bellevergue, T. Grand-Perret, M. Ajakane, V. Baudet, P. Boissin, E. Boursier, F. Loriolle, L. Duhamel, D. Charon, and J. Kirilovsky. 1991. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:15771-15781.
46. van der Geer, P., and T. Hunter. 1994. Phosphopeptide mapping and phosphoamino acid analysis by electrophoresis and chromatography on thin-layer cellulose plates. Electrophoresis 15:544-554.
47. Vesely, J., L. Havlicek, M. Strnad, J. J. Blow, A. Donella-Deana, L. Pinna, D. S. Letham, J.-Y. Kato, L. Detivaud, S. Leclerc, and L. Meijer. 1994. Inhibition of cyclin-dependent kinases by purine analogues. Eur. J. Biochem. 224:771-786.
48. Vilcek, J., and G. C. Sen. 1996. Interferons and other cytokines, p. 375-399. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.). Fields virology. Lippincott-Raven Publishers, Philadelphia, Pa.
49. 2+/calmodulin-dependent protein kinase II. J. Neurochem. 56:294-298.
50. Yankulov, K., K. Yamashita, R. Roy, J.-M. Egly, and D. L. Bentley. 1995. The transcriptional elongation inhibitor 5,6-dichloro-l-β-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase. J. Biol. Chem. 270:23922-23925.
51. Zandomeni, R., M. C. Zandomeni, D. Shugar, and R. Weinmann. 1986. Casein kinase type II is involved in the inhibition by 5,6-dichloro-l-β-D-ribofuranosylbenzimidazole of specific RNA polymerase II transcription. J. Biol. Chem. 261:3414-3419.